257 results about "Nap" patented technology

A network-based system and method for providing anonymous voice communications using the telephone network and data communications links under the direction of a Call Broker and associated network elements. A user (the call initiator) present in a text chat room session establishes a data connection to Call Broker and, after qualifying for access (e.g., using credit card information) and providing a callback number, receives voice session information and participant access codes for each desired participant in a voice call. The initiator causes session information and participant codes to be passed to one or more selected chat participants in the current text chat room. When a selected participant uses the received session information, and enters the received participant code and a callback number, the Call Broker in cooperation with a Network Adjunct Processor (NAP) completes voice links to the initiator and the selected participant(s). The need for each party to have a second subscriber line is advantageously avoided by having the Call Broker arrange to have one or more voice links completed through a VoIP link, and further reduces the need for second lines for participants by forwarding a Call Broker—placed call to a busy participant line to the participant's Internet Service Provider (ISP), which then sends a message to the participant announcing one or more options for receiving the incoming call, including receiving the incoming call through a VoIP link.

A wireless communication system is provided for rapidly establishing the QoS resource on different communication networks. In this system, the NAP evaluates a network resource used by the MT, and generates the QoS history information unit indicating the evaluation result. The AAA authenticates the QoS history information unit generated by the NAP. The NAP transmits the authenticated QoS history information unit to the MT. The MT request for a resource establishment to the NAP when switching the communicating party from the NAP to the NAP, and transmits the QoS history information unit. The NAP verifies the authenticity of the QoS history information unit to the AAA when receiving the request for resource establishment from the MT and allocates the network resource to the MT based on the QoS history information unit.

An apparatus and method for stimulating animal tissue (for example to trigger a nerve action potential (NAP) signal in a human patient) by application of both electrical and optical signals for treatment and diagnosis purposes. The application of an electrical signal before or simultaneously to the application of a NAP-triggering optical signal allows the use of a lower amount of optical power or energy than would otherwise be needed if an optical signal alone was used for the same purpose and effectiveness. The application of the electrical signal may precondition the nerve tissue such that a lower-power optical signal can be used to trigger the desired NAP, which otherwise would take a higher-power optical signal were the electric signal not applied. Some embodiments include an implanted nerve interface having a plurality of closely spaced electrodes placed transversely and / or longitudinally to the nerve and a plurality of optical emitters.

A head support system for supporting the user's head in an at least generally upright disposition, while the user, for example, naps or sleeps or otherwise rests while traveling sitting in a seat. The head support element (1) interfaces with the underside of and, preferably, up and around the front of the chin, i.e., the mental proturberance with its central clef, and underneath the user's chin and from side-to-side of and along side the chin, i.e., the mandible body, in “face-to-face” surface engagement over a relatively large area, essentially forming a supportive cup for the chin, with a self-supporting but soft, solid block of molded, supportive material having an oblong shape with a reduced sized central portion (10) for hand grasping, with its angled, flat bottom (31) resting centrally on the central upper chest area of the user, preferably over and across the manubrium sterni area, with an anchoring strap (41) positioned, for example, around and about the back of the user's neck. The support element is at least generally “Y” shaped with a laterally enlarged base (30) when viewed from the front (FIG. 2). The anchoring strap subsystem (40) includes a “break-away” string-like line (42) attached to the strap with terminal ends (42a / 42b) that extend to the front loosely connected to the block and extend through and past a push-button / barrel lock (43).

A fabric-based electronic device sleeve with a stiff directional nap lining the interior of a pocket. The directional nap (or plush) of the fabric is oriented to permit easy slidable insertion of an electronic device into the sleeve's pocket, with static friction forces between the directional nap and the device preventing the device from slipping out on its own or falling from the sleeve when held in a downward direction. As a user removes the electronic device from the sleeve, a gentle pull upon pinching the device between thumb and index finger overcomes the static friction forces between the device and the directional nap lining to permit easy removal and access.

System and method are disclosed for bridging a point-to-point network such as a Bluetooth scatternet with a shared medium network such as an Ethernet LAN. The scatternet is connected to the LAN via a network access point (NAP). Data packets sent from the LAN to the scatternet are filtered at the NAP to eliminate unnecessary data packets from being sent to the scatternet. Only certain ones of the data packets are forwarded between the LAN and the scatternet. An inter-NAP protocol is used to exchange messages where two or more NAPs are connected to the LAN. Broadcast loops are prevented from occurring in the scatternet and the LAN by defining Administrative domains and NAP service areas (NAPSAs), and controlling the borders thereof according to a broadcast type of the data packets.

An apparatus and method for stimulating animal tissue (for example to trigger a nerve action potential (NAP) signal in a human patient) by application of both electrical and optical signals for treatment and diagnosis purposes. The application of an electrical signal before or simultaneously to the application of a NAP-triggering optical signal allows the use of a lower amount of optical power or energy than would otherwise be needed if an optical signal alone was used for the same purpose and effectiveness. The application of the electrical signal may precondition the nerve tissue such that a lower-power optical signal can be used to trigger the desired NAP, which otherwise would take a higher-power optical signal were the electric signal not applied. Some embodiments include an implanted nerve interface having a plurality of closely spaced electrodes placed transversely and / or longitudinally to the nerve and a plurality of optical emitters.

The invention provides an application of polypeptide hydrogel serving as a protein vaccine adjuvant and a protein vaccine. The hydrogel has good biocompatibility and can stimulate an organism to produce antigen-specific body fluid and cellular immune response very well after physically mixed with a protein antigen simply. According to the application, the polypeptide sequence is Nap-GFFY-OMe.

A system and method for managing battery energy usage by a mobile wireless network which detects threshold conditions for network signal found and lost; records historical events of signal found and lost with operational criteria associated with operational conditions of the events such as time, day, date, tower number, and geographic location; upon each detection of network signal loss, determines from the recorded event records a nap termination condition upon which network signal has been historically reliable; and enters a battery-saving nap mode until the nap termination condition is met.

A method and a subscriber device for implementing an NSP selection. The method includes: when a subscriber device accesses a network, obtaining information of an NAP accessible at current location; when the subscriber device stores the information of NSPs accessible for the NAP, obtaining the information of NSPs accessible for the NAP; otherwise, receiving the information of NSPs accessible for the NAP from the network side; adding the information of accessible NSPs to the information of available NSPs; and selecting an NSP from the available NSPs for a service of the subscriber device. Therefore, extra occupation on air interface resources is lowered, and the time consumption during the network discovering and selecting process is effectively lowered.

Method and apparatus for optically and electrically stimulating neurons of auditory nerve pathways of a person to provide auditory sensations for the person including generating a plurality of pulsed light signals having one or more successive pulses, delivering the plurality of pulsed light signals to one or more auditory nerve pathways of the cochlea of the person and selectively controlling the plurality of light signals to optically stimulate and trigger nerve action potentials (NAPs) in the one or more auditory nerve pathways. In some embodiments, the present invention also includes one or more electrical stimulation electrodes used to stimulate the low frequency portions of the auditory nerves.

Novel dual-targeted, bifunctional anti-influenza drugs formed by conjugation with anti-inflammatory agents are disclosed. Exemplary drugs according to the invention include caffeic acid (CA)-bearing zanamivir (ZA) conjugates ZA-7-CA (1), ZA-7-CA-amide (7) and ZA-7-Nap (43) for simultaneous inhibition of influenza virus neuraminidase and suppression of proinflammatory cytokines. Synthetic methods for preparation of these enhanced anti-influenza conjugate drugs are provided. The synthetic bifunctional ZA conjugates act synergistically towards protection of mice lethally infected by H1N1 or H5N1 influenza viruses. The efficacy of ZA-7-CA, ZA-7-CA-amide and ZA-7-Nap conjugates is much greater than the combination therapy of ZA with anti-inflammatory agents.